Zdrowie i gospodarka · 31/07/2013

FDA Hosts Public Workshop on Trial Designs for Liver Disease Secondary to NAFLD

The FDA, in collaboration with the American Association for the Study of Liver Diseases (AASLD), is hosting a 2-day public workshop to discuss trial designs and endpoints for clinical trials in nonalcoholic fatty liver disease (NAFLD) and its complications, with the goal of promoting efficient drug development and improved treatments for patients.